ANNEX I, Decision_act (EU) 2004/696

In forcesince 23 Dec 2005

[Rapid tests and primary molecular tests.]

(in EUR)

Disease | Member State | Rate tests performed | Maximum amount

TSEs | Austria | 100 % | 2076000

Belgium | 100 % | 3586000

Cyprus | 100 % | 503000

Czech Republic | 100 % | 1736000

Denmark | 100 % | 2426000

Estonia | 100 % | 294000

Finland | 100 % | 1170000

France | 100 % | 29755000

Germany | 100 % | 15170000

Greece | 100 % | 1487000

Hungary | 100 % | 1184000

Ireland | 100 % | 6172000

Italy | 100 % | 8397000

Lithuania | 100 % | 836000

Luxembourg | 100 % | 155000

Malta | 100 % | 36000

Netherlands | 100 % | 4840000

Portugal | 100 % | 1540000

Slovenia | 100 % | 444000

Spain | 100 % | 8536000

Sweden | 100 % | 363000

United Kingdom | 100 % | 5690000

Total | 96396000

Changed on 23 Dec 2005

Cyprus | 100 % | 353000503000

Italy | 100 % | 86770008397000

Netherlands | 100 % | 45100004840000 Portugal | 100 % | 14800001540000

Spain | 100 % | 88460008536000 Sweden | 100 % | 313000363000

  1. 23 Dec 2005 – todayin force
  2. 4 Jun 2005 – 23 Dec 2005earlier wording
  3. 14 Oct 2004 – 4 Jun 2005earlier wording

Versions are held from 14 Oct 2004; the article may be older.